Hydrix share price rockets 250% following announcement

The Hydrix share price skyrocketed 215% by 3pm today following the company’s positive AngelMed Guardian device announcement.

| More on:
Digitised heart rate and share price chart with man on ipad in background signifying share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Hydrix Ltd (ASX: HYD) share price blasted off today (and that’s no exaggeration), gaining more than 253% to trade at 31.5 cents just prior to the market’s close. And this on a day when the All Ordinaries Index (ASX: XAO) is down 0.8%. So what’s driving the Hydrix share price, a small company with a market capitalisation of only $28 million?

Hydrix share price leaps on implantable heart attack warning system

The Hydrix share price took off after the medical product innovation company released an announcement to the ASX today reporting success with the first supply and implant of its AngelMed Guardian device.

AngelMed is the first implantable heart attack warning system to receive approval by the United States Food and Drug Administration (FDA). The company announced that four of its implants were performed in Singapore last week and that all four patients have now been released from hospital.

Hydrix medical field Clinical Engineers supported each implant via real-time remote support from Angel Medical Systems staff in the US.

The latest good news for Hydrix follows the company’s 13 March announcement that it had acquired an exclusive 7-year distribution agreement for AngelMed Guardian spanning eight Asia Pacific countries.

A significant milestone

Addressing the company’s latest success, Gavin Coote, Hydrix Executive Chairman said:

“The AngelMed Guardian implants are a significant milestone for Hydrix and AngelMed. This achievement demonstrates strong execution of our buy, build, invest strategy to create product revenue and earnings streams, and of equal importance, reflects progress in our aspiration to meaningfully improve a billion lives”.

Founder and Chairman of Angel Medical Systems David Fischell added:

“We are very pleased with the success of these first Asia Pacific implants and excited about the large potential market opportunity. It has been a global team effort in getting to this point…”

The implanted devices will gather data over a 2-week period to establish each patient’s baseline heart signal before the device is calibrated and the alarm configuration customised.

AngelMed Guardian uses artificial intelligence and machine learning algorithms to monitor patients’ heart signals to warn of acute coronary syndrome events, including silent heart attacks.

The company estimates 500,000 people annually suffer from an acute coronary syndrome event in the top four Asia Pacific countries it is initially targeting.

With today’s meteoric rise, the Hydrix share price is up 43% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A group of friends watch the game at the pub whilst enjoying a few drinks, one girl has her hand up cheering.
Consumer Staples & Discretionary Shares

Players gonna play: 3 ASX shares set for a strong reporting season

There are some consumer activities that don't just disappear because of an economic downturn. Here are some stocks that could…

Read more »

a young farmer stands back and admires his work in arranging bales of hay to form a house shape with two bales balancing against each other to form a roof, perched on bales tipped on their side in an abstract house shape on a freshly harvested paddock.
Small Cap Shares

2 ASX shares you never heard of ready to make hay

Plummeting stock prices don't necessarily reflect the prospects of many businesses at the moment.

Read more »

Investor sitting in front of multiple screens watching share prices
Share Market News

5 things to watch on the ASX 200 on Thursday

The ASX 200 is expected to have a better day on Thursday...

Read more »

Two hands being shaken symbolising a deal.
Mergers & Acquisitions

How many global mega deals involved ASX 200 shares in the first half of 2022?

Deal making among ASX 200 shares helped drive a 25.4% increase in M&A activity in Australia in the first half…

Read more »

Top 10 blank list on chalkboard
Share Market News

Here are the top 10 ASX shares today

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

a sad looking engineer or miner wearing a high visibility jacket and a hard hat stands alone with his head bowed and hand to his forehead as he speaks on a mobile telephone out front of what appears to be an on site work shed.
Resources Shares

Should investors dig the BHP share price in July?

BHP shares are sinking. Is it time to jump on the ASX mining giant?

Read more »

a man peers between two large piles of papers and files with a wide-eyed, wide-mouth look of dread at the amount of work he has to do.
Share Market News

Here are the 3 most heavily traded ASX 200 shares on Wednesday

We take a look at the most traded ASX 200 shares by volume today.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Healthcare Shares

Why this broker is tipping the ResMed share price to rise 17%

A leading broker says ResMed shares can rise strongly from here...

Read more »